WEX Pharmaceuticals Inc:企業の戦略的SWOT分析

◆英語タイトル:WEX Pharmaceuticals Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C15784
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

WEX Pharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

WEX Pharmaceuticals Inc (WEX), a subsidiary of CK Life Sciences Int’l., (Holdings) Inc., is a clinical stage biotechnology company that focuses on the discovery, development, manufacture and commercialization of drugs for pain management. The company develops a new class of non-opioid analgesics utilizing its proprietary platform technology TTX (Tetrodotoxin or TTX). TTX is a non-peptide neurotoxin, non-addictive alternative to opioids, and a sodium channel blocker. WEX’s clinical candidates include TEC-006 and TTX-CINP-201. TEC-006 is being studied for the treatment of moderate to severe cancer related pain and TTX-CINP-201 is being developed for moderate to severe neuropathic pain caused by chemotherapy in patients with cancer. WEX is headquartered in Vancouver, British Columbia, Canada.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
WEX Pharmaceuticals Inc – Key Facts
WEX Pharmaceuticals Inc – Key Employees
WEX Pharmaceuticals Inc – Key Employee Biographies
WEX Pharmaceuticals Inc – Major Products and Services
WEX Pharmaceuticals Inc – History
WEX Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
WEX Pharmaceuticals Inc – Business Description
WEX Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
WEX Pharmaceuticals Inc – Strengths
WEX Pharmaceuticals Inc – Weaknesses
WEX Pharmaceuticals Inc – Opportunities
WEX Pharmaceuticals Inc – Threats
WEX Pharmaceuticals Inc – Key Competitors
Section 3 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
WEX Pharmaceuticals Inc, Key Facts
WEX Pharmaceuticals Inc, Key Employees
WEX Pharmaceuticals Inc, Key Employee Biographies
WEX Pharmaceuticals Inc, Major Products and Services
WEX Pharmaceuticals Inc, History
WEX Pharmaceuticals Inc, Key Competitors

★海外企業調査レポート[WEX Pharmaceuticals Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AmWINS Group Inc:企業のM&A・事業提携・投資動向
    AmWINS Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AmWINS Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • K S Oils Limited:戦略・SWOT・企業財務分析
    K S Oils Limited - Strategy, SWOT and Corporate Finance Report Summary K S Oils Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Khatam al-Anbia:企業の戦略的SWOT分析
    Khatam al-Anbia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • H.C. Starck GmbH:企業の戦略的SWOT分析
    H.C. Starck GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • EffRx Pharmaceuticals SA:製薬・医療:M&Aディール及び事業提携情報
    Summary EffRx Pharmaceuticals SA (EffRx), formerly EffRx Inc is a pharmaceutical company that develops and commercializes prescription medications for specialty indications. The company offers therapeutics for men and women with musculoskeletal, genitourinary and endocrine disorders. It provides com …
  • Beam Suntory Inc.:企業の戦略・SWOT・財務情報
    Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report Summary Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Biocept Inc (BIOC):企業の製品パイプライン分析2018
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Ryanair Holdings plc:企業の戦略・SWOT・財務分析
    Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kenya Power and Lighting Co Ltd (KPLA):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Tubacero S. de RL de CV:企業の戦略・SWOT・財務分析
    Tubacero S. de RL de CV - Strategy, SWOT and Corporate Finance Report Summary Tubacero S. de RL de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Chiyoda Corporation (6366)-石油・ガス分野:企業M&A・提携分析
    Summary Chiyoda Corporation (Chiyoda) is an engineering services provider that offers various services along with its subsidiaries. Its offerings include project management, program management, feasibility studies, front end engineering design works, engineering, procurement, construction, commissio …
  • Enel Russia (ENRU):電力:M&Aディール及び事業提携情報
    Summary Enel Russia, a subsidiary of Enel Investment Holding BV, is an energy utility. It produces electricity and thermal energy. The company generates electricity using coal, gas and fuel oil sources. Enel Russia owns and operates Konakovskaya GRES, Nevinnomysskaya GRES, Reftinskaya GRES and Sredn …
  • LeasePlan Corporation N.V.:戦略・SWOT・企業財務分析
    LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report Summary LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • GMR Infrastructure Ltd (GMRINFRA):電力:M&Aディール及び事業提携情報
    Summary GMR Infrastructure Limited (GMR), a subsidiary of GMR Group, is a construction company. The company executes various projects across airport, energy, transportation and urban infrastructure sectors. The company owns and operates Delhi's Indira Gandhi International Airport, Rajiv Gandhi Inter …
  • Secom Co., Ltd.:企業の戦略・SWOT・財務情報
    Secom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Secom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • City National Wealth Management:企業の戦略・SWOT・財務情報
    City National Wealth Management - Strategy, SWOT and Corporate Finance Report Summary City National Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC):企業の財務・戦略的SWOT分析
    Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view …
  • Pattern Energy Group Inc.:企業のM&A・事業提携・投資動向
    Pattern Energy Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pattern Energy Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Pictet & Cie Group SCA:企業の戦略・SWOT・財務情報
    Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report Summary Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Iroko Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Iroko Pharmaceuticals LLC (Iroko) is a pharmaceutical company that develops treatment options for responsible pain management. The company’s products comprise low dose Nonsteroidal anti-inflammatory drugs such as meloxicam, indomethacin, and diclofenac that are in various stages of nonclinic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆